Europe Osteoarthritis Injectables Market Size & Outlook

The osteoarthritis injectables market in Europe is expected to reach a projected revenue of US$ 2,372.3 million by 2030. A compound annual growth rate of 5.7% is expected of Europe osteoarthritis injectables market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,606.0
Forecast, 2030 (US$M)
$2,372.3
CAGR, 2024 - 2030
5.7%
Report Coverage
Europe

Europe osteoarthritis injectables market, 2018-2030 (US$M)

Europe

Europe osteoarthritis injectables market highlights

  • The Europe osteoarthritis injectables market generated a revenue of USD 1,606.0 million in 2023.
  • The market is expected to grow at a CAGR of 5.7% from 2024 to 2030.
  • In terms of segment, hyaluronic acid injections was the largest revenue generating injection type in 2023.
  • Hyaluronic Acid Injections is the most lucrative injection type segment registering the fastest growth during the forecast period.
  • Country-wise, Denmark is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 1,606.0 million
Market revenue in 2030USD 2,372.3 million
Growth rate5.7% (CAGR from 2023 to 2030)
Largest segmentHyaluronic acid injections
Fastest growing segmentHyaluronic Acid Injections
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCorticosteroid Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Acetylsalicylic Acid (ASA) Injections
Key market players worldwideAnika Therapeutics Inc, Bioventus Inc Class A, Ferring, Sanofi SA, Zimmer Biomet Holdings Inc, Arthrex, Pacira BioSciences Inc, Royal Biologics, Teva Pharmaceutical Industries Ltd


Other key industry trends

  • In terms of revenue, Europe region accounted for 22.2% of the global osteoarthritis injectables market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,809.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Osteoarthritis Injectables Market Companies

Name Profile # Employees HQ Website

Europe osteoarthritis injectables market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to osteoarthritis injectables market will help companies and investors design strategic landscapes.


Hyaluronic acid injections was the largest segment with a revenue share of 38.73% in 2023. Horizon Databook has segmented the Europe osteoarthritis injectables market based on corticosteroid injections, hyaluronic acid injections, platelet-rich plasma (prp) injections, placental tissue matrix (ptm) injections, acetylsalicylic acid (asa) injections covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe osteoarthritis injectables market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe osteoarthritis injectables market databook

  • Our clientele includes a mix of osteoarthritis injectables market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe osteoarthritis injectables market , including forecasts for subscribers. This continent databook contains high-level insights into Europe osteoarthritis injectables market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe osteoarthritis injectables market size, by country, 2018-2030 (US$M)

Europe Osteoarthritis Injectables Market Outlook Share, 2023 & 2030 (US$M)

Europe osteoarthritis injectables market size, by country, 2018-2030 (US$M)

Related regional statistics

No records

No related regions found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more